U.S. Stocks in Motion | After Reaching a Settlement Agreement with UnitedHealthcare, Liquidia (LQDA.US) Surges Over 25% in Early Trading

Zhito Finance APP has learned that on Wednesday, Liquidia (LQDA.US) surged more than 25% in early trading and is now quoted at $33.72. On the news front, the company previously announced that it had reached a $380.7 million settlement agreement with United Therapeutics Corporation, ending years of legal disputes over its pulmonary arterial hypertension treatment product. The agreement, announced on Tuesday, resolved six pending lawsuits between the two parties. At the same time, the agreement also allows Liquidia to continue selling its inhaled formulation YUTREPIA for the treatment of pulmonary arterial hypertension (PAH) without any interruption.